文献速递癫痫神经重症与神经感染

快速反应脑电图自动癫痫负荷估计器的准确性:AccuRASE研究

Accuracy of a Rapid-Response EEG's Automated Seizure-Burden Estimator: AccuRASE Study.
PubMed 文献 · Neurology · 2024-12-26

该回顾性观察研究在耶鲁纽黑文医院等三家医院纳入2019年11月至2021年2月的连续临床快速反应脑电图(rr-EEG)检查,由三名评审者盲法判读,以2/3一致为参考标准,评估自动癫痫负荷估计器(ASBE)检测脑电状态性癫痫(ESE)或可能ESE的阴性预测值和阳性预测值。结果显示>10%负荷阈值阴性预测值高(ESE 99%,ESE/pESE 98%),>90%阈值特异性高但敏感性低。

要点

  • >10%负荷阈值检测ESE/pESE的敏感性为88%,阴性预测值98%,可作为筛查工具排除ESE。
  • >90%负荷阈值检测ESE/pESE特异性99%,阳性预测值78%,但敏感性降至29%。
  • ASBE软件在多数需快速反应脑电图患者中无需专家复核即可可靠排除ESE(<10%负荷阈值阴性预测值98%)。

核心结论

  • ASBE在>90%癫痫负荷阈值下检测ESE和ESE/pESE具有高特异性,对ESE/pESE阳性预测值良好,但敏感性仅低至中等;该阈值可用于帮助分诊患者以立即治疗/转运、紧急专家复核和附加连续脑电图(CEEG)。
  • >10%阈值具有高敏感性,可检测约85%的ESE患者;在该较低阈值下,可作为筛查工具以>95%的阴性预测值排除ESE。

研究设计与样本

  • 回顾性观察研究,采用多名盲法评审者。
  • 纳入2019年11月至2021年2月在耶鲁纽黑文医院、一家附属社区医院和一家附属市内区域医院实施的所有连续临床rr-EEG检查。
  • 三名评审者盲法判读每份脑电图,参考标准为2/3一致。

主要发现

  • 在最初2小时内,>10%负荷阈值检测单纯ESE的敏感性为86%(95%CI 42%-100%),检测ESE/pESE的敏感性为88%(68%-97%)。
  • >10%阈值对ESE的阴性预测值为99%(97%-100%),对ESE/pESE为98%(95%-100%);对ESE的特异性为79%(73%-84%),对ESE/pESE为84%(79%-89%)。
  • >10%阈值对ESE的阳性预测值为11%(4%-23%),对ESE/pESE为39%(26%-53%)。
  • >90%阈值检测ESE的特异性为97%(94%-99%),阳性预测值33%(7%-70%);检测ESE/pESE的特异性为99%(97%-100%),阳性预测值78%(40%-97%)。
  • >90%阈值检测ESE/pESE的敏感性降至29%(13%-51%),检测ESE的敏感性为43%(10%-82%)。

关键数值与推荐

  • ASBE软件在<10%负荷阈值下排除ESE的阴性预测值为98%。
  • >10%负荷阈值的阴性预测值>95%。
  • >90%负荷阈值检测ESE/pESE的阳性预测值为78%(40%-97%)。

临床怎么用

  • 在>90%负荷阈值下,ASBE可用于帮助分诊患者以立即治疗/转运、紧急专家复核和附加CEEG。
  • 在>10%负荷阈值下,ASBE可作为筛查工具,以>95%的阴性预测值排除ESE。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The use of rapid response EEG (rr-EEG) has recently expanded in limited-resource settings and as a supplement to conventional EEG to rapidly detect and treat nonconvulsive status epilepticus. The study objective was to test the accuracy of an rr-EEG's automated seizure burden estimator (ASBE). METHODS: This is a retrospective observational study using multiple blinded reviewers. All consecutive clinical rr-EEG procedures performed between November 2019 and February 2021 at Yale New Haven Hospital, one affiliated community hospital, and one affiliated inner-city regional hospital were included. Three reviewers blindly reviewed each EEG. The reference standard was 2/3 agreement. The co-primary outcome measures were the negative predictive value (NPV) of the ASBE for the detection of electrographic status epilepticus (ESE) or possible ESE (ESE/pESE) (to be used as a screening method to exclude ESE without the need for urgent expert review) and the positive predictive value (PPV, to be used for immediate treatment without requiring urgent expert review). These were assessed using a variety of seizure burden cutoffs determined by the algorithm (>1%, >10%, >20%, >50%, and >90%). RESULTS: In the first 2 hours, a >10% burden cutoff detected 86% (95% CI 42%-100%) of studies with ESE alone and 88% (68%-97%) with ESE/pESE; this >10% cutoff had a NPV of 99% (97%-100%) for ESE and 98% (95%-100%) for ESE/pESE. The specificity at this threshold was 79% (73%-84%) for ESE and 84% (79%-89%) for ESE/pESE, but the PPV was low at 11% (4%-23%) for ESE and 39% (26%-53%) for ESE/pESE. A >90% burden cutoff was 97% (94%-99%) specific for detecting ESE (PPV 33% [7%-70%]) and 99% (97%-100%) specific for detecting ESE/pESE [PPV 78% (40%-97%)], although the sensitivity dropped significantly to 29% (13%-51%) for ESE/pESE and 43% (10%-82%) for ESE at the >90% threshold. DISCUSSION: The ASBE has high specificity at >90% seizure burden threshold for detecting ESE and ESE/pESE, with good PPV for ESE/pESE, though with only low-to-moderate sensitivity; at this threshold, it can be used to help triage patients for immediate treatment/transfer, urgent expert review, and additional CEEG. A >10% threshold has a high sensitivity, detecting approximately 85% of patients with ESE; at this lower cutoff, it can be used as a screening tool to exclude ESE with >95% NPV. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that ASBE software can reliably exclude ESE (98% negative predictive value using a <10% burden cutoff) without expert review in most patients requiring rapid response EEG.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sheikh ZB, Dhakar MB, Fong MWK, et al. Accuracy of a Rapid-Response EEG's Automated Seizure-Burden Estimator: AccuRASE Study. Neurology. 2024. PMID: 39724534. doi:10.1212/WNL.0000000000210234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。